- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02795793
Non-operative Management for Appendicitis in Children (APRES)
A Prospective Randomised Controlled Non-inferiority Study to Evaluate the Effectiveness and Safety (APRES) of Non-operative Management in Children With Acute Uncomplicated Appendicitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Appendicectomy for acute appendicitis is one of the most commonly performed paediatric emergency operations in Australia. This standard treatment of acute uncomplicated appendicitis (AUA) has remained largely unchallenged since its introduction in the late nineteenth century, under the assumption that AUA progresses to perforation and thus complications should an operation be withheld. However, appendicectomy via laparoscopic or open approach is not without its risks.
Non-operative management (NOM) with antibiotics has been increasingly accepted as mainstay therapy for many intra-abdominal infections. In fact, children with appendicitis complicated by perforation, abscess or phlegmon formation are often preferentially treated non-operatively with antibiotic therapy, with or without percutaneous drainage. Systematic reviews and meta-analyses have demonstrated that antibiotics are a safe and effective treatment for AUA in adults and there is growing evidence that NOM is safe and effective in children.
Primary objectives:
To determine the safety and efficacy of non-operative antibiotic management of clinically diagnosed likely AUA in children.
Secondary objectives:
- To compare the safety and efficacy of NOM of clinically diagnosed likely AUA with operative management (OM) in children.
- To assess the cost-effectiveness of NOM of clinically diagnosed likely AUA against OM in children.
- To assess the feasibility and acceptability of NOM of appendicitis in children.
This study will enrol 226 patients, age 5-16 years, with acute uncomplicated appendicitis at two tertiary children's hospitals. Allocation ratio of 1:1 will be made via weighted minimisation using the following criteria: age (5-8 years or 9-16 years), gender (male or female), and duration of symptoms (<48 or >48 hours).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Susan Adams, MBBS
- Phone Number: 61 02 9382 1776
- Email: susan.adams@unsw.edu.au
Study Contact Backup
- Name: Jonathan Karpelowsky, MBBCh
- Phone Number: 61 02 9845 3349
- Email: jonathan.karpelowsky@health.nsw.gov.au
Study Locations
-
-
New South Wales
-
Randwick, New South Wales, Australia, 2031
- Recruiting
- Sydney Children's Hospital
-
Contact:
- Susan Adams, MBBS
-
Principal Investigator:
- Susan Adams, MBBS
-
Westmead, New South Wales, Australia, 2145
- Not yet recruiting
- The Children's Hospital at Westmead
-
Contact:
- Jonathon Karpewlosky, MBBCh
-
Principal Investigator:
- Jonathon Karpelowsky, MBBCh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 5 and 15 years;
- Clinical diagnosis by at least one paediatric surgeon (or duty surgical registrar) of acute uncomplicated appendicitis based on with a combination of clinical, laboratory and/or imaging findings; that before the study would have led to the decision to recommend been subjected to an appendicectomy.
Exclusion Criteria: if one or more of the following is assessed to be present
- Suspicion of perforated appendicitis on the basis of generalised peritonitis and/or imaging studyA diagnosis of perforated or complicated appendicitis (e.g. peritonitis, appendiceal mass) is made on the basis of clinical, laboratory and/or imaging findings;
- Previous non-operative treatment of acute appendicitis;
- Age younger than 5 years or older than 16 years;
- Known intolerance or allergy to Piperacillin with Tazobactam;
- Known history of inflammatory bowel disease, or other chronic abdominal pain syndrome;
- Known concurrent significant illness;
- Unable to obtain informed consent from parents or guardian;
- Known to have a cognitive impairment, an intellectual disability or a mental illness that would impair participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-operative management group (NOM)
Children in the NOM group will receive intravenous Piperacillin with Tazobactam (Tazocin) 100mg/kg/dose every 8 hours for at least 24 hours, and they will be observed and reassessed within 24 hours after randomisation.
A further 24 hours of intravenous Piperacillin with Tazobactam therapy will be offered to children in invariable condition.
A clinical decision will be made by the attending surgeon to offer OM if a patient's condition deteriorates at any time, or if a patient has failed to improve after 48 hours of intravenous antibiotic therapy.
Once the patient is clinically improving and tolerating oral intake, the antibiotic regimen will be changed to oral Amoxicillin plus Clavulanic acid (Augmentin) 22.5mg/kg/dose twice per day to complete a total seven day course of antibiotics.
Oral Ciprofloxacin 15mg/kg/dose twice daily and oral Metronidazole 10mg/kg/dose twice daily will be offered to children who are known to have an intolerance or allergy to Amoxicillin or Clavulanic acid.
|
With intravenous Piperacillin with Tazobactam (Tazocin)
|
Active Comparator: Appendectomy group (Operative management, OM)
Children allocated to OM may receive preoperative antibiotic prophylaxis as clinically indicated.
Appendicectomy will be performed laparoscopically, or via open surgery according to the surgeon's standard practice.
Postoperative antibiotic treatment will be determined on the basis of intraoperative findings in accordance with the institutional practice.
The appendix specimen will be examined by a paediatric pathologist, and the formal histopathology report will be recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Unplanned or unnecessary operation(s) and complications
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unplanned or unnecessary operation, or complications
Time Frame: 6 months
|
6 months
|
|
Length of primary hospital stay
Time Frame: 72 hours
|
Time of randomisation to discharge
|
72 hours
|
Treatment-related complications
Time Frame: 12 months
|
12 months
|
|
Redamission and Emergency Department presentation
Time Frame: 12 months
|
12 months
|
|
Cost of treatment in Australian Dollars (AUD)
Time Frame: 12 months
|
12 months
|
|
Return to school from time of randomisation
Time Frame: 30 days
|
30 days
|
|
Return to normal activities from time of randomisation
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HERC/15/SCHN/266
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appendicitis
-
North Estonia Medical CentreTartu University HospitalRecruitingAcute Appendicitis | Appendicitis Acute | Appendicitis Perforated | Acute Appendicitis With Rupture | Appendicitis; Perforation | Acute Appendicitis Without Peritonitis | Acute Appendicitis With Appendix AbscessEstonia
-
University of MichiganCompletedAppendicitis | Complicated Appendicitis | Perforated Appendicitis | Ruptured AppendicitisUnited States
-
HJ23Hospital Universitari Joan XXIII de Tarragona.Not yet recruitingAcute Appendicitis | Appendicitis Perforated | Appendicitis Suppurative
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedAppendicitis | Appendicitis Acute | Appendiceal Abscess | Appendicolith | Appendicitis With Perforation | Appendicitis PeritonitisItaly
-
Johns Hopkins All Children's HospitalCompleted
-
Pirogov Russian National Research Medical UniversityCompletedAcute Appendicitis | Acute Appendicitis With Rupture | Acute Appendicitis Without Peritonitis | Acute Appendicitis With PeritonitisRussian Federation
-
Phoenix Children's HospitalTerminatedComplicated Appendicitis | Perforated AppendicitisUnited States
-
Faculty Hospital Kralovske VinohradyCompletedAppendicitis | Appendicitis Acute | Retrocecal AppendicitisCzechia
-
King Abdulaziz UniversityCompletedAppendicitis | Acute Appendicitis | Pathology | Appendicitis (Diagnosis)Saudi Arabia
-
Mauro PoddaAssociazione Chirurghi Ospedalieri ItalianiCompletedAcute Appendicitis | Appendectomy | Antibiotic Therapy | Appendicitis RecurrentItaly
Clinical Trials on Non-operative management group (NOM)
-
Baylor College of MedicineTerminatedPneumothoraxUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustActive, not recruitingEmergencies | Hernia | Surgery--ComplicationsUnited Kingdom
-
The Cleveland ClinicTerminatedCovid19 | Cholecystitis, Acute | Cholecystitis | Appendicitis | Cholecystitis; GallstoneUnited States
-
University of Missouri-ColumbiaTerminatedMetacarpal FractureUnited States
-
University of British ColumbiaCompleted
-
Cedars-Sinai Medical CenterUnknown
-
Mount Sinai Hospital, CanadaRecruiting
-
Columbia UniversityNot yet recruiting
-
University of Maryland, BaltimoreCompletedPain | Sacroiliac Joint | PelvisUnited States
-
University of Maryland, BaltimoreIndiana University HealthCompletedLC Pelvic FractureUnited States